IL228604A0 - Synthesis of 5-azacytidine - Google Patents
Synthesis of 5-azacytidineInfo
- Publication number
- IL228604A0 IL228604A0 IL228604A IL22860413A IL228604A0 IL 228604 A0 IL228604 A0 IL 228604A0 IL 228604 A IL228604 A IL 228604A IL 22860413 A IL22860413 A IL 22860413A IL 228604 A0 IL228604 A0 IL 228604A0
- Authority
- IL
- Israel
- Prior art keywords
- azacytidine
- synthesis
- Prior art date
Links
- NMUSYJAQQFHJEW-UHFFFAOYSA-N 5-Azacytidine Natural products O=C1N=C(N)N=CN1C1C(O)C(O)C(CO)O1 NMUSYJAQQFHJEW-UHFFFAOYSA-N 0.000 title 1
- NMUSYJAQQFHJEW-KVTDHHQDSA-N 5-azacytidine Chemical compound O=C1N=C(N)N=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 NMUSYJAQQFHJEW-KVTDHHQDSA-N 0.000 title 1
- 229960002756 azacitidine Drugs 0.000 title 1
- 230000015572 biosynthetic process Effects 0.000 title 1
- 238000003786 synthesis reaction Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/12—Triazine radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
- C07H1/06—Separation; Purification
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/582—Recycling of unreacted starting or intermediate materials
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161470392P | 2011-03-31 | 2011-03-31 | |
| PCT/US2012/031059 WO2012135405A1 (en) | 2011-03-31 | 2012-03-29 | Systhesis of 5-azacytidine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL228604A0 true IL228604A0 (en) | 2013-12-31 |
Family
ID=46000343
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL228604A IL228604A0 (en) | 2011-03-31 | 2013-09-29 | Synthesis of 5-azacytidine |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US9951098B2 (https=) |
| EP (1) | EP2691408B1 (https=) |
| JP (1) | JP6289361B2 (https=) |
| KR (1) | KR20140019820A (https=) |
| CN (1) | CN103619864A (https=) |
| AU (1) | AU2012236476A1 (https=) |
| BR (1) | BR112013025167A2 (https=) |
| IL (1) | IL228604A0 (https=) |
| MX (1) | MX2013010945A (https=) |
| RU (1) | RU2013148580A (https=) |
| SG (1) | SG193622A1 (https=) |
| WO (1) | WO2012135405A1 (https=) |
| ZA (1) | ZA201307142B (https=) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3782612B1 (en) | 2008-05-15 | 2023-11-08 | Celgene Corporation | Oral formulations of cytidine analogs and methods of use thereof |
| WO2012106299A1 (en) | 2011-01-31 | 2012-08-09 | Celgene Corporation | Pharmaceutical compositions of cytidine analogs and methods of use thereof |
| US9968627B2 (en) | 2013-03-26 | 2018-05-15 | Celgene Corporation | Solid forms comprising 4-amino-1-β-D-ribofuranosyl-1,3,5-triazin-2(1H)-one and a coformer, compositions and methods of use thereof |
| WO2014169216A2 (en) | 2013-04-11 | 2014-10-16 | Carnegie Mellon University | TEMPLATE-DIRECTED γPNA SYNTHESIS AND γPNA TARGETING COMPOUNDS |
| WO2014169206A2 (en) | 2013-04-11 | 2014-10-16 | Carnegie Mellon University | Divalent nucleobase compounds and uses therefor |
| CN103450303A (zh) * | 2013-09-04 | 2013-12-18 | 重庆泰濠制药有限公司 | 阿扎胞苷晶型a、阿扎胞苷晶型b及其制备方法 |
| CN104672289A (zh) * | 2013-11-29 | 2015-06-03 | 南京圣和药业股份有限公司 | 一种阿扎胞苷杂质的制备方法 |
| WO2017183215A1 (ja) * | 2016-04-21 | 2017-10-26 | 大原薬品工業株式会社 | ５－アザシチジン類の糖部シリルエーテル誘導体 |
| CN114907272A (zh) | 2016-09-26 | 2022-08-16 | 卡耐基梅隆大学 | 二价核碱基化合物及其用途 |
| CN109305992A (zh) * | 2017-07-28 | 2019-02-05 | 江苏先声药业有限公司 | 一种阿扎胞苷的制备方法 |
| CN109988207B (zh) * | 2017-12-29 | 2022-01-04 | 江苏豪森药业集团有限公司 | 阿扎胞苷晶型的制备方法 |
| CN110092807A (zh) * | 2018-01-30 | 2019-08-06 | 中国医学科学院药物研究所 | 一种高纯、低灼烧残渣的制备阿扎胞苷的方法 |
| JP7017638B2 (ja) | 2018-02-07 | 2022-02-08 | ラブレス バイオメディカル リサーチ インスティテュート | 吸入可能な乾燥粉末シチジン類似体組成物及び癌への治療として使用する方法 |
| KR20190136284A (ko) * | 2018-05-30 | 2019-12-10 | 주식회사 삼양바이오팜 | 안정한 아자시티딘-함유 약제학적 조성물의 제조방법 |
| WO2022113069A1 (en) | 2020-11-24 | 2022-06-02 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | E protein channel blockers and orf3 inhibitors as anti-covid-19 agents |
| BR112022022243A2 (pt) | 2020-05-01 | 2022-12-20 | Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd | Bloqueadores do canal de proteína e e inibidores de orf3 como agentes anti-covid-19. |
| CN113201039B (zh) * | 2021-05-19 | 2022-04-29 | 南京德克瑞医药化工有限公司 | 一种医药中间体2’,3’,5’-三乙酰阿扎胞苷的制备方法 |
| AR134497A1 (es) | 2023-11-28 | 2026-01-21 | Sanofi Sa | Combiterapia multifuncional con activador de los linfocitos citolíticos naturales (nk) para tratar trastornos neoplásicos hemáticos |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1050899A (https=) | 1963-12-22 | |||
| CH527207A (de) | 1968-05-08 | 1972-08-31 | Ceskoslovenska Akademie Ved | Verfahren zur Herstellung von 1-Glycosyl-5-azacytosinen |
| CH507969A (de) | 1968-11-12 | 1971-05-31 | Ceskoslovenska Akademie Ved | Verfahren zur Herstellung von 1-Glycosyl-5-azacytosinen |
| DE2012888C3 (de) | 1970-03-14 | 1981-04-02 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | Verfahren zur Herstellung von 5-Azapyrimidinnucleosiden |
| FR2123632A6 (en) | 1971-01-26 | 1972-09-15 | Ceskoslovenska Akademie Ved | Prepn of 5-azacytosines and 5-azacytidines - from bis trimethylsilyl-5-azacytosine |
| DE2122991C2 (de) | 1971-05-04 | 1982-06-09 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | Verfahren zur Herstellung von Cytosin- und 6-Azacytosinnucleosiden |
| DE2508312A1 (de) | 1975-02-24 | 1976-09-02 | Schering Ag | Neues verfahren zur herstellung von nucleosiden |
| DE2757365A1 (de) | 1977-12-20 | 1979-06-21 | Schering Ag | Neues verfahren zur herstellung von nucleosiden |
| IL129126A0 (en) * | 1996-10-16 | 2000-02-17 | Icn Pharmaceuticals | Monocyclic l-nucleosides analogs and uses thereof |
| AU2003278904A1 (en) | 2002-09-24 | 2004-04-19 | Kornis Pharmaceuticals, Incorporated | 1, 3, 5-triazines for treatment of viral diseases |
| US7189740B2 (en) | 2002-10-15 | 2007-03-13 | Celgene Corporation | Methods of using 3-(4-amino-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for the treatment and management of myelodysplastic syndromes |
| US6943249B2 (en) | 2003-03-17 | 2005-09-13 | Ash Stevens, Inc. | Methods for isolating crystalline Form I of 5-azacytidine |
| US7038038B2 (en) | 2003-03-17 | 2006-05-02 | Pharmion Corporation | Synthesis of 5-azacytidine |
| US6887855B2 (en) | 2003-03-17 | 2005-05-03 | Pharmion Corporation | Forms of 5-azacytidine |
| CA2535889A1 (en) | 2003-08-29 | 2005-03-17 | Aton Pharma, Inc. | Combination methods of treating cancer |
| US7192781B2 (en) | 2004-04-13 | 2007-03-20 | Pharmion Corporation | Methods for stabilizing 5-azacytidine in plasma |
| US20060069060A1 (en) | 2004-09-27 | 2006-03-30 | Sanjeev Redkar | Salts of decitabine |
| US20060063735A1 (en) | 2004-09-17 | 2006-03-23 | Supergen, Inc. | Salts of 5-azacytidine |
| US20080057086A1 (en) | 2006-09-01 | 2008-03-06 | Pharmion Corporation | Colon-targeted oral formulations of cytidine analogs |
| EP2644614A3 (en) | 2007-01-11 | 2014-02-26 | IVAX Pharmaceuticals s.r.o. | Solid state forms of 5-azacytidine and processes for preparation thereof |
| US20110288042A1 (en) | 2007-08-02 | 2011-11-24 | Chemagis Ltd. | Stable highly pure azacitidine and preparation methods therefor |
| EP2048151A1 (en) | 2007-10-10 | 2009-04-15 | Cilag AG | Method for producing nucleosides by direct glycosylation of the nucleoside base |
| EP2211870A1 (en) | 2007-11-01 | 2010-08-04 | Celgene Corporation | Cytidine analogs for treatment of myelodysplastic syndromes |
| EP3782612B1 (en) | 2008-05-15 | 2023-11-08 | Celgene Corporation | Oral formulations of cytidine analogs and methods of use thereof |
| WO2010014883A2 (en) | 2008-08-01 | 2010-02-04 | Dr. Reddy's Laboratories Ltd. | Azacitidine process and polymorphs |
| EP2324042B1 (en) | 2008-08-06 | 2012-11-28 | Sicor, Inc. | Process for preparing azacytidine intermediate |
| AR073003A1 (es) | 2008-08-08 | 2010-10-06 | Scinopharm Taiwan Ltd | Proceso para preparar 5-azacitosina nucleosidos y sus derivados |
| US20110042247A1 (en) | 2009-06-25 | 2011-02-24 | Chandrasekhar Kocherlakota | Formulations of azacitidine and its derivatives |
| IT1399195B1 (it) | 2010-03-30 | 2013-04-11 | Chemi Spa | Processo per la sintesi di azacitidina e decitabina |
-
2012
- 2012-03-29 MX MX2013010945A patent/MX2013010945A/es not_active Application Discontinuation
- 2012-03-29 AU AU2012236476A patent/AU2012236476A1/en not_active Abandoned
- 2012-03-29 WO PCT/US2012/031059 patent/WO2012135405A1/en not_active Ceased
- 2012-03-29 BR BR112013025167A patent/BR112013025167A2/pt not_active IP Right Cessation
- 2012-03-29 JP JP2014502770A patent/JP6289361B2/ja active Active
- 2012-03-29 CN CN201280026401.3A patent/CN103619864A/zh active Pending
- 2012-03-29 US US14/007,955 patent/US9951098B2/en active Active
- 2012-03-29 EP EP12716820.1A patent/EP2691408B1/en active Active
- 2012-03-29 KR KR1020137028446A patent/KR20140019820A/ko not_active Withdrawn
- 2012-03-29 SG SG2013071915A patent/SG193622A1/en unknown
- 2012-03-29 RU RU2013148580/04A patent/RU2013148580A/ru not_active Application Discontinuation
-
2013
- 2013-09-23 ZA ZA2013/07142A patent/ZA201307142B/en unknown
- 2013-09-29 IL IL228604A patent/IL228604A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN103619864A (zh) | 2014-03-05 |
| JP6289361B2 (ja) | 2018-03-07 |
| SG193622A1 (en) | 2013-11-29 |
| WO2012135405A1 (en) | 2012-10-04 |
| ZA201307142B (en) | 2015-11-25 |
| EP2691408B1 (en) | 2017-06-28 |
| EP2691408A1 (en) | 2014-02-05 |
| KR20140019820A (ko) | 2014-02-17 |
| BR112013025167A2 (pt) | 2019-09-24 |
| JP2014510755A (ja) | 2014-05-01 |
| RU2013148580A (ru) | 2015-05-10 |
| US20140128593A1 (en) | 2014-05-08 |
| US9951098B2 (en) | 2018-04-24 |
| MX2013010945A (es) | 2014-03-12 |
| AU2012236476A1 (en) | 2013-05-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL228604A0 (en) | Synthesis of 5-azacytidine | |
| IL258327A (en) | Synthesis of antiviral compounds | |
| IL252345B (en) | Intermediate compounds for the synthesis of antiviral compounds | |
| IL237581B (en) | Derivatives of 6-oxo-pyrazinopyrrolopyrimidines | |
| HUE047354T2 (hu) | Ivacaftor deuterizált származékai | |
| SMT201700302T1 (it) | Derivati deuterati di ivacaftor | |
| ZA201403995B (en) | Stereoselective total synthesis of noribogaine | |
| EP2712362A4 (en) | MANUFACTURE OF LACTO-N-TETRAOSE | |
| PL2755957T3 (pl) | Synteza związków triazolopirymidynowych | |
| IL230976A (en) | Crystalline forms of Czebitaxel | |
| ZA201503913B (en) | Synthesis of zsm-5 | |
| PL2771326T3 (pl) | Synteza związków triazolopirymidynowych | |
| IL222474A0 (en) | Method of synthesis | |
| SI2630118T1 (sl) | Sinteza aliskirena | |
| IL223926A0 (en) | Synthesis of cyclopentaquinazolines | |
| EP2684869A4 (en) | PREPARATION OF 3-MERCAPOTOPROPIONATES | |
| EP2791349A4 (en) | SYNTHESIS OF N-ACETYL-D-NEURAMIC ACID | |
| EP2760876A4 (en) | NEW PROCESS FOR SYNTHESIS OF FUCOSE | |
| ZA201208995B (en) | Method of synthesis | |
| TWM390349U (en) | Structure of door-in-door | |
| TWM386865U (en) | Residue-filtering structure of juice-extractor | |
| IL229109A0 (en) | Cancer diagnosis | |
| TWM388315U (en) | Improved structure of hemoclip | |
| TWM400763U (en) | Improved structure of cold-accumulating cravats | |
| TWM390745U (en) | Structure improvement of tea-making can |